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Volume 50, Number 4 Abstracts 967Table II. Patency rates in claudicant patients treated
with endovascular modality
6 mos 12 mos 18 mos 24 mos 30 mos
Primary patency
BPG
65.6  8.4 51.6  9.1 25.8  8.3 22.1  7.9 22.1  7.9
Primary patency
No BPG
93.7  2.2 75.4  4.3 64.7  4.9 60.2  5.2 58.1  5.5
Primary patency P
Values
.0001 .0001 .0001 .0001 .0001
Primary assisted
patency BPG
87.3  6.0 75.9  8.0 70.5  9.1 65.1  9.9 65.1  9.9
Primary assisted
patency No
BPG
96.8  1.6 90.9  2.8 87.1  3.4 83.8  4.0 79.5  4.8
Primary assisted
patency P
Values
.031 .025 .031 .023 .039
Secondary patency
BPG
90.4  5.3 90.4  5.3 83.9  7.9 77.5  9.6 77.5  9.6
Secondary patency
No BPG
98.4  1.1 96.4  1.8 94.8  2.4 91.3  3.3 91.3  3.3
Secondary patency
P values
.03 .13 .06 .05 .05
BPG, Bypass grafting.
Long-Term Outcomes of Diabetic Patients Undergoing Endovascular
Infrainguinal Interventions
Abularrage CJ, Conrad MF, Crawford RS, et al
Objectives: Diabetes has traditionally predicted poor outcomes after
lower extremity revascularization for peripheral vascular disease (PVD). The
purpose of this studywas to assess the influence of diabetes on long-termoutcomes
of percutaneous translumininal angioplasty (PTA) in patients with PVD.
Methods: From January 2002 to December 2007, 1075 patients
underwent PTA. Endpoints including primary patency (PP), assisted pa-
tency (AP), limb salvage, and survival were evaluated in the entire cohort, as
well as in diabetic (DM) and non-diabetic (non-DM) patients, using Kaplan-
Meier and Cox regression analyses.
Results: There were 533 DM and 542 non-DM patients. Significant
clinical and demographic features are summarized in the Table. Median
follow-up was 34 months. In the entire cohort, the five-year PP was 42% 
2.4%, AP was 81%  2.0%, limb salvage was 89%  1.6%, and survival was
60%  2.2%. On univariate analysis, diabetes was associated with inferior
five-year PP (DM: 37%  3.4% vs. non-DM: 46%  3.3%, P .009), limb
salvage (84% 2.6% vs. 93% 1.8%, P .0001), and survival (52% 3.2%
vs. 68%  2.9%, P  .0001). Assisted patency did not differ between DM
and non-DM (P  .18). In the entire cohort, DM (1.25; [1.01-1.54]; P 
.04), single vessel peroneal runoff (1.54; [1.16-2.08]; P .003), and dialysis
(1.59; [1.10-2.33]; P  .02) were associated with decreased PP on multi-
variate analysis. DM was also an independent predictor of death after PTA
(1.32; [1.02-1.67]; P  .03). Critical limb ischemia and dialysis were the
only variables on multivariate analysis to predict both limb loss and death.
Conclusions: Diabetes is an independent predictor of decreased PP
and death after PTA. Although acceptable assisted patency rates can be
achieved with close surveillance and reintervention, long-term limb salvage
and survival remain inferior in the diabetic population due to a more severe
cardiovascular risk profile and clinical presentation.
Table. Clinical and demographic features
DM Non-DM P
Male gender 368 (69%) 323 (60%) .001
Coronary artery disease 368 (69%) 293 (54%) .0001
Dialysis 56 (11%) 22 (4%) .0001
Critical limb ischemia 284 (53%) 155 (24%) .0001
Single vessel runoff 205 (38%) 126 (23%) .0001
Multi-level intervention 125 (23%) 83 (15%) .0007
Isolated tibial intervention 58 (11%) 31 (6%) .002
DM, Diabetic.
Outcomes of Endoluminal Re-intervention for Recurrent Disease after
Percutaneous Iliac Angioplasty and Stenting
Davies MG, Bismuth J, Naoum J, Houssan H, Peden EK, Lumsden ABObjectives: Endovascular therapy for symptomatic atherosclerotic iliac
artery stenosis is common but is associated with a significant restenosis rate.This study evaluates the outcomes of percutaneous therapy for symptomatic
restenosis (50% on angiography) after iliac intervention at a national
academic medical center.
Methods: We performed a retrospective analysis of records from
patients who underwent endovascular intervention for symptomatic athero-
sclerotic iliac artery stenosis and were followed by duplex ultrasound be-
tween January 1990 and January 2009.
Results: Eight hundred seventy-nine patients underwent 1444 iliac
artery interventions. One hundred fifty-six vessels restenosed with an actuarial
restenosis rate of 20%  2% at five years. Presenting symptoms, angioplasty
alone, a concurrent occluded superficial femoral artery (SFA), and increasing
complexity of the iliac intervention were associated with restenosis. One
hundred forty of these restenoses (90%) were associated with recurrent
symptoms. One hundred nine (78%) underwent repeat angioplasty and 31
underwent bypass surgery. The remainder were observed. The 109 percu-
taneous interventions were performed in  patients (57%male; average age,
58 years; range, 38-87 years). Eighty-five percent had hypertension, 76%
had hyperlipidemia, 54% had metabolic syndrome, 41% were considered
diabetic, and 17% had chronic renal insufficiency (eGFR60). There was a
1% technical failure rate. Comparisons of demographics, presenting symp-
toms, and outcomes between those patients undergoing intervention for a
primary lesion and those for a recurrent lesion are shown in the Table. By
Cox proportional hazards and multivariate analysis, presenting symptoms,
female gender, and eGFR 60ml negatively influenced cumulative patency
of recurrent lesions. An occluded SFA but not TASC lesion negatively
influences cumulative patency of recurrent lesions. Restenosis and recurrent
symptoms were tightly associated
Conclusions: Percutaneous re-intervention for iliac artery restenosis is
safe and effective with equivalent outcomes to primary intervention. The
patients are more likely to be younger and of female gender than patients
presenting for primary intervention. Both patency and functional outcomes
after re-intervention are worse than primary interventions.
Table. Demographic variables and outcomes
Primary Recurrent P value
Gender (% male) 61 57 ns
Age (mean  SD; years) 65  12 58  11 ns
30-day mortality (%) 1 1 ns
Morbidity (%) 4 4 .05
Cumulative patency (% patent)* 95  2 83  2 .05
Restenosis (% free)* 87  3 61  5 .01
Clinical benefit (% retained)* 87  2 74  2 .05
*Mean  SEM at five years follow up.
Limb Ischemia During Femoral Cannulation for Cardiopulmonary
Support
Foley PJ, Morris RJ, Woo EY, Acker MA, Wang GJ, Jackson BM
Objectives: Extracorporeal membrane oxygenation and extracorporeal
cardiopulmonary support (ECMO/CPS) are potentially life-saving techniques
for patients with cardiopulmonary collapse. Complications include lower ex-
tremity ischemia from femoral cannulation. We examined the outcomes of
patients placed on ECMO/CPS, including the rate of limb ischemia.
Methods:All instances of ECMO/CPS over a three-year period (2006
to 2009) at a single university hospital were examined retrospectively for:
cannulation strategy, perfusion strategy, mortality, and limb ischemia. Po-
tential predictors of limb ischemia with femoral artery cannulation were age,
gender, body surface area (BSA), body mass index (BMI), and cannula size.
Results: Fifty-eight patients were placed on ECMO/CPS.Of these, 43
patients (74%) had femoral arterial cannulation. In 10 patients, the superfi-
cial femoral artery was cannulated prophylactically (without antecedent limb
ischemia), and perfused from a branch of the ECMO/CPS circuit. In seven
of the remaining 33 patients (21%), all male, limb ischemia developed,
requiring decannulation with fasciotomy (n  4) or additional cannulation
of the superficial femoral artery (SFA) with branching of the ECMO/CPS
circuit (n  3). One patient with ipsilateral leg ischemia required eventual
amputation. Patients with limb ischemia were significantly younger than
those who did not develop limb ischemia (P  .001). BSA, BMI, and
cannula size did not predict limb ischemia. Overall 30-day mortality follow-
ing the initiation of CPS/ECMO was 79%. There was no correlation
between limb ischemia and mortality.
Conclusions: Younger patients may be at increased risk for lower
extremity arterial insufficiency with femoral cannulation for ECMO/CPS.
Prophylactic or expectant SFA cannulation are reasonable approaches, and,
given that mortality does not increase with limb ischemia, SFA cannulation
from a branch of the circuit should be instituted liberally when required.
